IL-6 and IL-6R have been shown to promote tumor growth, and we previously identified the IL6R gene as one of the inflammation-related genes in a 14-gene prognostic signature in children with high-risk tumors lacking MYCN amplification [6]. This evidence concerns the gene IL6R and neoplasm.